Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients. Remsik, Wilcox et al.

Published: 7 January 2021| Version 1 | DOI: 10.17632/s7m535k6nt.1
Contributor:
Jan Remsik

Description

Targeted proteomics analyses of cerebrospinal fluid from four patient cohorts, as described in Remsik, Wilcox et al.

Files

Institutions

Memorial Sloan Kettering Cancer Center

Categories

Neurology, Neuroimmunology, Neuro-Inflammation, COVID-19

Licence